Hypopharyngeal cancer patient care evaluation

Laryngoscope

Volumn 107, Issue 8, 1997, Pages 1005-1017

  Hoffman, Henry T ^a   Karnell, Lucy H ^a   Shah, Jatin P ^a   Ariyan, Stephan ^a   Brown, G Stephen ^a   Fee, Willard E ^a   Glass, Andrew G ^a   Goepfert, Helmuth ^a   Ossoff, Robert H ^a   Fremgen, Amy M ^a  

^a AMERICAN COLLEGE OF SURGEONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONFERENCE PAPER; DEMOGRAPHY; FEMALE; HUMAN; HYPOPHARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DATA COLLECTION; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; REGISTRIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 0030793174     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199708000-00001     Document Type: Conference Paper

References (39)

1. Muir C, Weiland L. Upper aerodigestive tract cancers. Cancer 1995;75(suppl 1):147-53.
2. Ries LAG, Miller BA, Hankey BF, et al., eds. SEER Cancer Statistics Review, 1973-1991: Tables and Graphs, National Cancer Institute. NIH Pub. No. 94-2789, Bethesda, MD: NIH, 1994.
3. Moore C. Cigarette smoking and cancer of the mouth, pharynx, and larynx. JAMA 1971;4:553-8.
4. Maier H, Sennewald E, Heller G, et al. Chronic alcohol consumption: the key risk factor for pharyngeal cancer. Otolaryngol Head Neck Surg 1994;110:168-73.
5. Schantz SP, Spitz MR, Hsu TC. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst 1990;82:1773-5.
6. Sturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 1995;104:946-54.
7. Larsson L-G, Sandstrom A, Westling P. Relationship of Plummer-Vinson disease to cancer of the upper alimentary tract in Sweden. Cancer Res 1975;35:3308-16.
8. Bradford CR, Hoffman HT, Wolf GR, et al. Squamous carcinoma of the head and neck in organ transplant recipients: possible role of oncogenic viruses. Laryngoscope 1990; 100:190-4.
9. Morgan DW, Abdullah V, Quiney R, et al. Human papilloma virus and carcinoma of the laryngopharynx. J Laryngol Otol 1991;105:288-90.
10. Clayman GL, Stewart MG, Weber RS, et al. Human papilloma virus in larygneal and hypopharyngeal carcinomas. Arch Otolaryngol Head Neck Surg 1994;120:743-8.
11. Ward PH, Hanson DG. Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope 1988;98:1195-9.
12. Hussey DH, Latourette HB, Panje WR, et al. Head and neck cancer: an analysis of the incidence, patterns of treatment, and survival at the University of Iowa. Ann Otol Rhinol Laryngol 1991;100(suppl 152)100:1-6.
13. Shah JP, Shaha AR, Spiro RH, et al. Carcinoma of the hypopharynx. Am J Surg 1976;132:439-43.
14. Carpenter RJ, DeSanto LW, Devine KD, et al. Cancer of the hypopharynx: analysis of treatment and results in 162 patients. Arch Otolaryngol 1976;102:716-21.
15. Pingree TF, Davis RK, Reichman O, Derrick L. Treatment of hypopharyngeal carcinoma: a 10-year review of 1,362 cases. Laryngoscope 1987;97:901-4.
16. Clayman GL, Weber RS. Cancer of the hypopharynx and cervical esophagus. In: Myers EN, Suen JY, eds. Cancer of the Head and Neck, edn 3. Philadelphia: W.B. Saunders Co., .1996:chap 21.
17. Elias MM, Hilgers FJM, Keus RB, et al. Carcinoma of the pyriform sinus: a retrospective analysis of treatment results over a 20-year period. Clin Otolaryngol 1995; 20:249-53.
18. Andersen JW, Kalish LA. Biostatistical issues in the design and interpretation of clinical trials in head and neck cancer. In: Snow GB, Clark JR, eds. Multimodality Therapy for Head and Neck Cancer. New York: Georg Thieme Verlag Medical Publishers, Inc.; 1992.
19. Shah JP, Karnell LH, Hoffman HT, et al. Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol, in press.
20. Commission on Cancer. Data Acquisition Manual. Chicago: Commission on Cancer, American College of Surgeons; 1990.
21. World Health Organization. ICD-O: International Classification of Disease for Oncology. edn 2. Geneva: World Health Organization; 1990.
22. Beahrs O, Henson DE, Hutter RVP, Kennedy BJ, eds. Manual for Staging of Cancer. edn 4. Philadelphia: J.B. Lippincott Co.; 1992.
23. SPSS User's Guide, Release 5.0. SPSS Inc., Chicago: SPSS Inc.; 1992.
24. Hoffman HT, Karnell LH. Laryngeal cancer. In: Steele GD, Jessup JM, Winchester DP, Menck HR, Murphy GP, eds. Annual Review of Patient Care. Atlanta: American Cancer Society; 1995:84-100.
25. Lefebvre J-L, Buisset E, Coche-Dequeant B, et al. Epilarynx: pharynx or larynx? Head Neck 1995;Sept/Oct:377-81.
26. Raxack RS, Sako K, Marchetta FC, et al. Carcinoma of the hypopharynx: success and failure. Am J Surg 1977;134:489-91.
27. Lam KH, Ho CM, Wei WI, et al. Cancer of the hypopharynx: Asian perspectives in management. In: Johnson JT, Didolkar MS, eds. Head and Neck Cancer, Vol III. Amsterdam: Elsevier Science Publishers BV, Excepta Medica; 1993: 89-96
28. Saleh EM, Abdullwahab AA, Kammal MM. Age and sex incidence of hypopharyngeal tumours in upper Egypt: Assuit University experience. J Laryngol Otol 1995;109:737-40.
29. Chen TS, Chen PS. Rise and fall of the Plummer-Vinson syndrome. J Gastroenterol Hepatol 1994;9:654-8.
30. Brugere J, Guenel P, Leclerc A, et al. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer 1986;57:391-5.
31. Sessions RB, Harrison LB, Hong WK. Tumors of the larynx and hypopharynx. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology, edn 4. Philadelphia: J.B. Lippincott Co.; 1993: 631-47.
32. Leipzig B, Zellmer JE, Klug D. Panedoscopy study group: the role of endoscopy in evaluating patients with head and neck cancer. Arch Otolaryngol 1985;111:589-94.
33. McGuirt WF. Panendoscopy as a screening examination for simultaneous primary tumors in head and neck cancer: a prospective sequential study and review of the literature. Laryngoscope 1982;92:569-76.
34. Benninger MS, Enrique RR, Nichols RD. Symptom-directed selective endoscopy and cost containment for evaluation of head and neck cancer. Head Neck 1993;15:532-6.
35. Steiner W, Stenglein C, Fietkau R, et al. Therapy of hypopharyngeal cancer. Part IV: long-term results of transoral laser microsurgery of hypopharyngeal cancer. HNO 1994; 42:147-56.
36. Theile DR, Robinson DW, Theile DE, et al. Free jejunal interposition reconstruction after pharyngolaryrtgectomy: 201 consecutive cases. Head Neck 1995;17:83-8.
37. Weber RS, Goepfert H. Cancer of the hypopharynx and cervical esophagus. In: Myers EN, Suen JY, eds. Cancer of the Head and Neck. edn 2. New York: Churchill Livingstone; 1989:chap 21.
38. Garden AS, Morrison WH, Clayman GL, et al. Early squamous cell carcinoma of the hypopharynx: outcomes of treatment with radiation alone to the primary disease. Head Neck 1996;18:317-22.
39. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996;88:890-9.